🇺🇸 FDA
Pipeline program

R-CDOP

CSPC-DMS-NHL-001

Unknown other active

Quick answer

R-CDOP for Diffuse Large B Cell Lymphoma is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Diffuse Large B Cell Lymphoma
Phase
Unknown
Modality
other
Status
active

Clinical trials